Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show Post author: Post published:April 23, 2024 Post category:uncategorized Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign. You Might Also Like Researchers uncover new mechanism of action between nutrient adaptation of intestinal stem cells and aging February 12, 2024 Study sheds light on the promising role of virtual reality in treating depression May 6, 2024 PCORI funds more than $150 million to support new patient-centered clinical effectiveness research April 23, 2024
Researchers uncover new mechanism of action between nutrient adaptation of intestinal stem cells and aging February 12, 2024
PCORI funds more than $150 million to support new patient-centered clinical effectiveness research April 23, 2024